Philip P. Boudreau, EVP AND CFO at ABBOTT LABORATORIES (ABT), bought 2,200 shares at $91.50 ($201K) on 2026-04-23, disclosed to the SEC on 2026-04-27.
Abbott Laboratories CFO Philip Boudreau purchased 2,200 shares for $201,300, marking the largest purchase of his career and a rare reversal after 14 consecutive sales. This significant insider buying comes as the stock trades near its 52-week low, potentially signaling confidence in the valuation despite recent headwinds.
The stock is down 27.98% over the past year and is currently 33.27% below its 52-week high of $139.06, trading near the bottom of its range at $92.80.
Something here stands out, but not much.
| Filing → |
| ABT | SELL | 2021-10-27 | $1.0M | — | Filing → |
| ABT | SELL | 2020-03-16 | $869K | — | Filing → |